Investing.com - Veracyte Inc (NASDAQ: VCYT) reported first quarter EPS of $-0.02, $0.14 better than the analyst estimate of $-0.16. Revenue for the quarter came in at $96.84M versus the consensus estimate of $93.37M.
Guidance
Veracyte Inc sees FY 2024 revenue of $402.00M-$410.00M versus the analyst consensus of $398.30M.
Veracyte Inc's stock price closed at $21.03. It is down -17.76% in the last 3 months and down -7.07% in the last 12 months.
Veracyte Inc saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Veracyte Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Veracyte Inc's Financial Health score is "great performance".
Check out Veracyte Inc's recent earnings performance, and Veracyte Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar